3rd Quarter - Report

ALKERMES, INC. for ALKERMES, INC.

Period 3rd Quarter 2013 Filed Oct 21, 2013 Signed by Kathryn L. Biberstein, SVP and Chief Legal Officer

Official filing
Firm
ALKERMES, INC.
Client
ALKERMES, INC.
Income
—
Expenses
$147,660
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discuss need for educational resources and status of Vivitrol in public health.

LobbyistCovered position, as disclosed
ROBERT FORMAN —
PETER NORMAN New —

Contacted: HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); Natl Institutes of Health (NIH); Natl Institute on Alcohol Abuse & Alcoholism (NIAA); Office of Natl Drug Control Policy (NDCP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.